Pretreatment of P815 mastocytoma cells with inhibitors of protein synthesis reduces their susceptibility to lysis by cytotoxic thymus-derived lymphocytes.
D000818:Animals; D002448:Cell Adhesion; D002460:Cell Line; D003208:Concanavalin A / Q000276:immunology; D003513:Cycloheximide / Q000276:immunology / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic; D006183:H-2 Antigens / Q000276:immunology; D008285:Major Histocompatibility Complex; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D014176:Protein Biosynthesis; D012513:Sarcoma, Experimental / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D006183:H-2 Antigens; D003208:Concanavalin A; D003513:Cycloheximide